125 related articles for article (PubMed ID: 37993172)
1. Interleukin-18 in cancer immunology and immunotherapy.
Cirella A; Olivera I; Luri-Rey C; Bolaños E; Berraondo P; Melero I
Expert Opin Ther Targets; 2023; 27(11):1035-1042. PubMed ID: 37993172
[TBL] [Abstract][Full Text] [Related]
2. Intratumoral Gene Transfer of mRNAs Encoding IL12 in Combination with Decoy-Resistant IL18 Improves Local and Systemic Antitumor Immunity.
Cirella A; Bolaños E; Di Trani CA; de Andrea CE; Sánchez-Gregorio S; Etxeberria I; Gonzalez-Gomariz J; Olivera I; Brocco D; Glez-Vaz J; Luri-Rey C; Azpilikueta A; Rodríguez I; Fernandez-Sendín M; Egea J; Eguren I; Sanmamed MF; Palencia B; Teijeira A; Berraondo P; Melero I
Cancer Immunol Res; 2023 Feb; 11(2):184-198. PubMed ID: 36478221
[TBL] [Abstract][Full Text] [Related]
3. mRNAs encoding IL-12 and a decoy-resistant variant of IL-18 synergize to engineer T cells for efficacious intratumoral adoptive immunotherapy.
Olivera I; Bolaños E; Gonzalez-Gomariz J; Hervas-Stubbs S; Mariño KV; Luri-Rey C; Etxeberria I; Cirella A; Egea J; Glez-Vaz J; Garasa S; Alvarez M; Eguren-Santamaria I; Guedan S; Sanmamed MF; Berraondo P; Rabinovich GA; Teijeira A; Melero I
Cell Rep Med; 2023 Mar; 4(3):100978. PubMed ID: 36933554
[TBL] [Abstract][Full Text] [Related]
4. IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy.
Zhou T; Damsky W; Weizman OE; McGeary MK; Hartmann KP; Rosen CE; Fischer S; Jackson R; Flavell RA; Wang J; Sanmamed MF; Bosenberg MW; Ring AM
Nature; 2020 Jul; 583(7817):609-614. PubMed ID: 32581358
[TBL] [Abstract][Full Text] [Related]
5. Activation of the Interleukin-18 Signaling Pathway via Direct Receptor Dimerization in the Absence of Interleukin-18.
Mortazavi Y; Herrera R; Masureel M; Maculins T; Lehoux I; Sockolosky J; West N; Bulutoglu B; Zhao Y
J Interferon Cytokine Res; 2024 Jan; 44(1):37-42. PubMed ID: 37934469
[TBL] [Abstract][Full Text] [Related]
6. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
O'Malley BW; Li D; McQuone SJ; Ralston R
Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
[TBL] [Abstract][Full Text] [Related]
7. Intratumoral expression of interleukin 23 variants using oncolytic vaccinia virus elicit potent antitumor effects on multiple tumor models via tumor microenvironment modulation.
Chen L; Chen H; Ye J; Ge Y; Wang H; Dai E; Ren J; Liu W; Ma C; Ju S; Guo ZS; Liu Z; Bartlett DL
Theranostics; 2021; 11(14):6668-6681. PubMed ID: 34093846
[No Abstract] [Full Text] [Related]
8. Novel strategies exploiting interleukin-12 in cancer immunotherapy.
Cirella A; Luri-Rey C; Di Trani CA; Teijeira A; Olivera I; Bolaños E; Castañón E; Palencia B; Brocco D; Fernández-Sendin M; Aranda F; Berraondo P; Melero I
Pharmacol Ther; 2022 Nov; 239():108189. PubMed ID: 35430292
[TBL] [Abstract][Full Text] [Related]
9. Intratumoral aluminum hydroxide-anchored IL-12 drives potent antitumor activity by remodeling the tumor microenvironment.
Battula S; Papastoitsis G; Kaufman HL; Wittrup KD; Schmidt MM
JCI Insight; 2023 Dec; 8(23):. PubMed ID: 38063196
[TBL] [Abstract][Full Text] [Related]
10. Gene-Edited Interleukin CAR-T Cells Therapy in the Treatment of Malignancies: Present and Future.
Zhang Z; Miao L; Ren Z; Tang F; Li Y
Front Immunol; 2021; 12():718686. PubMed ID: 34386015
[TBL] [Abstract][Full Text] [Related]
11. Intratumoral immunotherapy with mRNAs encoding chimeric protein constructs encompassing IL-12, CD137 agonists, and TGF-β antagonists.
Cirella A; Bolaños E; Luri-Rey C; Di Trani CA; Olivera I; Gomis G; Glez-Vaz J; Pinci B; Garasa S; Sánchez-Gregorio S; Azpilikueta A; Eguren-Santamaria I; Valencia K; Palencia B; Alvarez M; Ochoa MC; Teijeira Á; Berraondo P; Melero I
Mol Ther Nucleic Acids; 2023 Sep; 33():668-682. PubMed ID: 37650116
[TBL] [Abstract][Full Text] [Related]
12. Bioengineering strategies to enhance the interleukin-18 bioactivity in the modern toolbox of cancer immunotherapy.
Taheri M; Tehrani HA; Daliri F; Alibolandi M; Soleimani M; Shoari A; Arefian E; Ramezani M
Cytokine Growth Factor Rev; 2024 Feb; 75():65-80. PubMed ID: 37813764
[TBL] [Abstract][Full Text] [Related]
13. Co-expression IL-15 receptor alpha with IL-15 reduces toxicity via limiting IL-15 systemic exposure during CAR-T immunotherapy.
Zhang Y; Zhuang Q; Wang F; Zhang C; Xu C; Gu A; Zhong WH; Hu Y; Zhong X
J Transl Med; 2022 Sep; 20(1):432. PubMed ID: 36167591
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy of cancer by IL-12-based cytokine combinations.
Weiss JM; Subleski JJ; Wigginton JM; Wiltrout RH
Expert Opin Biol Ther; 2007 Nov; 7(11):1705-21. PubMed ID: 17961093
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxicity in glioma cells due to interleukin-12 and interleukin-18-stimulated macrophages mediated by interferon-gamma-regulated nitric oxide.
Kito T; Kuroda E; Yokota A; Yamashita U
J Neurosurg; 2003 Feb; 98(2):385-92. PubMed ID: 12593627
[TBL] [Abstract][Full Text] [Related]
16. IL-15 armoring enhances the antitumor efficacy of claudin 18.2-targeting CAR-T cells in syngeneic mouse tumor models.
Shi H; Li A; Dai Z; Xue J; Zhao Q; Tian J; Song D; Wang H; Chen J; Zhang X; Zhou K; Wei H; Qin S
Front Immunol; 2023; 14():1165404. PubMed ID: 37564658
[TBL] [Abstract][Full Text] [Related]
17. Context-dependent role of IL-18 in cancer biology and counter-regulation by IL-18BP.
Fabbi M; Carbotti G; Ferrini S
J Leukoc Biol; 2015 Apr; 97(4):665-75. PubMed ID: 25548255
[TBL] [Abstract][Full Text] [Related]
18. Overcoming lung cancer immunotherapy resistance by combining nontoxic variants of IL-12 and IL-2.
Horton BL; D'Souza AD; Zagorulya M; McCreery CV; Abhiraman GC; Picton L; Sheen A; Agarwal Y; Momin N; Wittrup KD; White FM; Garcia KC; Spranger S
JCI Insight; 2023 Oct; 8(19):. PubMed ID: 37669107
[TBL] [Abstract][Full Text] [Related]
19. Antitumor effects of interleukin-12 (IL-12): applications for the immunotherapy and gene therapy of cancer.
Tahara H; Lotze MT
Gene Ther; 1995 Mar; 2(2):96-106. PubMed ID: 7719935
[TBL] [Abstract][Full Text] [Related]
20. IL-15/IL-15Rα Heterodimeric Complex as Cancer Immunotherapy in Murine Breast Cancer Models.
Guo S; Smeltz RB; Nanajian A; Heller R
Front Immunol; 2020; 11():614667. PubMed ID: 33628206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
